Publications by authors named "David Stockett"

Claim this Profile
H
Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks.
Rachael Elizabeth Hawtin, David Elliot Stockett, Oi Kwan Wong, Cecilia Lundin, Thomas Helleday

Oncotarget· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
Rachael E Hawtin, David E Stockett, Jo Ann W Byl, Robert S McDowell, Tan Nguyen

PLoS One· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Jennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, W Michael Flanagan, Raymond V Fucini, David E Stockett

Cancer Chemother Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
Andrew Conroy, David E Stockett, Duncan Walker, Michelle R Arkin, Ute Hoch

Cancer Chemother Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifications of the isonipecotic acid fragment of SNS-032: analogs with improved permeability and lower efflux ratio.
Junfa Fan, Bruce Fahr, David Stockett, Erica Chan, Sravanthi Cheeti

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diaminocyclohexyl analog of SNS-032 with improved permeability and bioavailability properties.
Ingrid C Choong, Iana Serafimova, Junfa Fan, David Stockett, Erica Chan

Bioorg Med Chem Lett· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-selectin up-regulation allows for targeted drug delivery in prostate cancer.
Vinay Bhaskar, Debbie A Law, Eric Ibsen, Danna Breinberg, Kellie M Cass, David Stockett

Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis